Abstract
We studied the outcome of allogeneic transplants in 135 patients who received selected BM and/or PBSC CD34+ cells from HLA haplo-identical related donors. Donor engraftment was achieved in 108 of 128 evaluable transplants. Engraftment failure occurred more often in non-malignant than in malignant diseases (10 of 25 vs 17 of 103, P = 0.010). The CD34+ cell dose was associated with the speed of neutrophil and platelet recovery, but the cell source was not. Acute GVHD (⩾grade II) developed in 21.0 ± 3.7%. Chronic GVHD occurred more frequently in malignancies than in non-malignancies (44.1 ± 7.6% vs 0.0%, P = 0.0075), and more in PBSC recipients than in BM recipients (53.6 ± 9.4% vs 17.4 ± 9.3%, P = 0.0054). Relapse rate was higher in high risk patients than in standard risk patients (78.7 ± 7.1% vs 22.1 ± 10.0%, P = 0.0001). Probabilities of disease-free survival (DFS) were 14.2 ± 3.5% in malignancies and 25.7 ± 9.2% in non-malignancies. Probabilities of DFS in standard and high risk patients were 39.4 ± 9.2% and 5.7 ± 2.8% (P = 0.0001). A high incidence of graft failure, infection and relapse was observed and resulted in high mortality. Bone Marrow Transplantation (2000) 26, 1281–1290.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells J Immunol 1984 133: 157–165
Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population Proc Natl Acad Sci USA 1992 89: 2804–2808
Berenson RJ, Andrews RG, Bensinger WI et al. Antigen CD34+ cells engraft lethally irradiated baboons J Clin Invest 1988 81: 951–955
Andrews RG, Bryant EM, Bartelmez SH et al. CD34+ marrow cells, devoid of T and B lymphocyte, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons Blood 1992 80: 1693–1701
Berenson RJ, Bensinger WI, Hill RS et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma Blood 1991 77: 1717–1722
Link H, Arseniev L, Bahre O et al. Transplantation allogeneic of CD34+ blood cells Blood 1996 87: 4903–4909
Yabe H, Yabe M, Hattori K et al. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors Bone Marrow Transplant 1996 17: 985–991
Finke J, Brugger W, Bertz H et al. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors Bone Marrow Transplant 1996 18: 1081–1086
Bensinger WI, Buckner CD, Shannon-Dorcy K et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy Blood 1996 88: 4132–4138
Urbano-Ispizua A, Rozman C, Martinez C et al. Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood Blood 1997 89: 3967–3973
Yasui M, Okamura T, Nakano T et al. CD34+ progenitor cell transplantation from HLA-mismatched family members to 21 children with high risk disorders Blood 1997 90: 399b
Yasui M, Park YD, Okamura T et al. CD34+ progenitor cell transplantation from two HLA-mismatched healthy fathers to two infants with severe aplastic anemia Int J Hematol 1998 67: 15–22
Matsuda Y, Hara J, Osugi Y et al. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors Bone Marrow Transplant 1998 21: 355–360
Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique Bone Marrow Transplant 1998 22: 519–525
Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T cell-depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186–1193
Cornelissen JJ, Fibbe WE, Schattenberg AVMB et al. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation Bone Marrow Transplant 1998 21: S66–S70
Kawano Y, Takaue Y, Watanabe A et al. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor Blood 1998 92: 3123–3130
Viret F, Chabannon C, Aurran-Schleinitz T et al. Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD Bone Marrow Transplant 1999 24: 225–227
Lang P, Schumm M, Taylor G et al. Clinical scale isolation of highly purified peripheral CD34+ progenitors for autologous and allogeneic transplantation in children Bone Marrow Transplant 1999 24: 583–589
Martin PJ, Hansen JA, Buchner CD et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts Blood 1985 66: 664–672
Verdonck LF, de Gast GC, van Heugten HG, Deccker A . A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation Blood 1990 75: 776–780
Schattenberg A, de Witte T, Preijers F et al. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation Blood 1990 75: 1356–1363
Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T cell-depleted haploidentical ‘three-loci’ incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 1994 84: 3948–3955
Patterson J, Prentice HG, Brenner MK et al. Graft failure following HLA-matched T-lymphocyte depleted bone marrow transplantation Br J Haematol 1986 63: 221–230
Marmont A, Horowitz MM, Gale RP et al. T cell depletion of HLA-identical transplants in leukemia Blood 1991 78: 2120–2130
Russell N, Gratwohl A, Schmitz N . The place of blood stem cells in allogeneic transplantation Br J Haematol 1996 93: 747–753
Miflin G, Russell NH, Hutchinson RM et al. Allogeneic peripheral blood stem transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD risk Bone Marrow Transplant 1997 19: 9–13
Solano C, Martinez C, Brunet S et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case–control study Bone Marrow Transplant 1998 22: 1129–1135
Mahmoud HK, Fahmy OA, Kamel A et al. Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 1999 24: 355–358
Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation Blood 1999 94: 455–464
Russell JA, Larratt L, Brown C et al. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome Bone Marrow Transplant 1999 24: 1177–1183
Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565–1577
Dreger P, Viehmann K, Steinmann J et al. G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1 Exp Hematol 1995 23: 147–154
Przepiorka D, Smith T, Folloder J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation Blood 1999 94: 1465–1470
Miyoshi H, Tanaka-Taya K, Nagae Y et al. Cytomegalovirus retinitis after transplantation of positively selected CD34+ cells from HLA-mismatched donors Pediatr Infect Dis J 1998 17: 345–348
Holmberg LA, Boeckh M, Hooper H et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation Blood 1999 94: 4029–4035
Martinez C, Urbano-Ispizua A, Rozman C et al. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts Exp Hematol 1999 27: 561–568
Osawa M, Hanada K, Hamada H, Nakauchi H . Long-term lymphohematological reconstitution by a single CD34− low/negative hematopoietic stem cell Science 1996 273: 242–245
Goodell MA, Rozenzweig M, Kim H et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable level of CD34 antigen exist in multiple species Nature Med 1997 3: 1337–1345
Morel F, Galy A, Chen B, Szilvassy SJ . Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34− fractions of Thy− 1 low Lin− low Sca−1+ bone marrow cells Exp Hematol 1998 26: 440–448
Sato T, Laver JH, Ogawa M . Reversible expression of CD34+ by murine hematopoietic stem cells Blood 1999 94: 2548–2554
Zanjani ED, Almeida-Porada G, Livingston AG et al. Human bone marrow CD34− cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells Exp Hematol 1998 26: 353–360
Bhatia M, Bonnet D, Murdoch B et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity Nature Med 1998 4: 1038–1045
Nakauchi Y . Hematopietic stem cells: are they CD34-positive or CD34-negative? Nature Med 1998 4: 1009–1010
Nakamura Y, Ando K, Chargui J et al. Ex vivo generation of CD34+ cells from CD34− hematopoietic cells Blood 1999 94: 4053–4059
Acknowledgements
This work was supported in part by the Grant-in-Aid for Cancer Research (10-1) from the Ministry of Health and Welfare of Japan. The authors thank Mr Toshiaki Tanaka, Dr Adam Tucker, Dr Yasuo Haruki and Ms Mari Sato for their assistance in statistical analysis and preparation of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kato, S., Yabe, H., Yasui, M. et al. Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Bone Marrow Transplant 26, 1281–1290 (2000). https://doi.org/10.1038/sj.bmt.1702707
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702707
Keywords
This article is cited by
-
Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study
Annals of Hematology (2021)
-
Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation
Bone Marrow Transplantation (2016)
-
Refinement of treatment strategies in ex vivo T-cell-depleted haploidentical SCT for pediatric patients
Bone Marrow Transplantation (2015)
-
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
Annals of Hematology (2015)
-
Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy
Bone Marrow Transplantation (2014)